Next Thursday, January 30, the next conference of the fourth edition of the Santander Biomedical Lectures program organized by IDIVAL, the University of Cantabria and the IBBTEC given by Dr. Xavier Bossuyt with the title “Laboratory evaluation of primary immunodeficiency” will take place. Dr. Bossuyt will describe the different approaches from the Immunology laboratory when […]

The Interlibrary Loan or Document Obtaining Service (SOD) is a basic form of cooperation between libraries that allows to complement the own fund with that of other libraries. That all libraries have everything subscribed is, in addition to unnecessary, economically unsustainable. The current logic, which the Marquise de Pelayo Library follows, is that all libraries […]

Project PI19/01580 “New immunotherapies for bladder cancer” directed by Dr. Carmen Álvarez Domínguez has been funded by the Carlos III Health Institute in the 2019 Call for Strategic Health Action 2017-2020, Health Research Projects for an amount of € 105,270. Bladder cancer is the fifth most common cancer with a higher prevalence in men than […]

Guillain-Barré syndrome (GBS) is the most common cause of acute neuropathic ascending paralysis in developed countries. Members of the IDIVAL Group of Neurodegenerative Diseases have carried out two studies on this syndrome. In the first study, published in Acta Neurologica Scandinavica “A unicenter, prospective study of Guillain ‐ Barré syndrome in Spain” the clinical characteristics, […]

The Valdecilla Health Research Institute Foundation (IDIVAL) is advancing in the knowledge of the genetic causes of Alzheimer's disease in the Spanish population through the promotion of research projects that the DEGESCO (Dementia Genetic Spanish Consortium) consortium has been developing in the last years. This consortium, founded in 2013 by doctors Pascual Sánchez-Juan, of the […]

The arrival of direct antiviral agents against hepatitis C virus (HCV) in 2014 was a before and after in the treatment of the disease. However, its high price made accurate estimates about the prevalence of hepatitis C virus (HCV) essential to guide health policies. For this reason, at the end of 2015 the digestive service […]

Digestive, Pathological Anatomy and Oncology Units of the Marques de Valdecilla University Hospital have published in MPDI, open access journal, a review of the porto-sinusoidal vascular disease associated with oxaliplatin. The article “Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It” is a review of the literature of a rare entity such […]

The Neuropediatrics service and the Genetics Unit of the Marques de Valdecilla University Hospital have published in the Frontiers Neuroscience the study “Rare Variants in 48 Genes Account for 42% of Cases of Epilepsy With or Without Neurodevelopmental Delay in 246 Pediatric Patients”, a collaborative work in which geneticists and neuropediatras from all over Spain […]

The Photonics Engineering Group of the UC-IDIVAL and the CIBER-BBN has developed a sensor system that, located in a rigid endoscope, makes it intelligent, facilitating spatial orientation in endoscopic surgery. This allows more efficient and effective operations and to reduce the stress of the surgeon during their operations. The work has been carried out by […]

The IDIVAL brand, an acronym for the Marques de Valdecilla Research Institute, created in 2014, has been cited more than 10,000 times by international biomedical literature, according to data obtained on the Web of Science platform recently. According to these data, the works published by the authors who have in their affiliation the Valdecilla brand […]